As presented in Fig. 6e, western blot analyses comparing T80 and FTSEC, among other ovarian tumor cell lines (namely, HEY and TOV21G epithelial ovarian carcinoma), show that T80 cells had significantly lower expression of wild-type EVI1 and EVI1Del190–515 with undetectable MDS1 or MDS1/EVI1 expression relative to FT194. Here, MECOM is linked to ovarian neoplasm.